纳米载体
细胞外小泡
疾病
药物输送
人口
生物
化学
生物技术
纳米技术
医学
药理学
细胞生物学
药品
病理
材料科学
环境卫生
作者
Sora Q. Kim,Kee‐Hong Kim
出处
期刊:Cells
[Multidisciplinary Digital Publishing Institute]
日期:2022-07-18
卷期号:11 (14): 2232-2232
被引量:75
标识
DOI:10.3390/cells11142232
摘要
Extracellular vesicles (EVs) are a highly heterogeneous population of membranous particles that are secreted by almost all types of cells across different domains of life, including plants. In recent years, studies on plant-derived nanovesicles (PDNVs) showed that they could modulate metabolic reactions of the recipient cells, affecting (patho)physiology with health benefits in a trans-kingdom manner. In addition to its bioactivity, PDNV has advantages over conventional nanocarriers, making its application promising for therapeutics delivery. Here, we discuss the characteristics of PDNV and highlight up-to-date pre-clinical and clinical evidence, focusing on therapeutic application.
科研通智能强力驱动
Strongly Powered by AbleSci AI